Skip to content
10-Q

Quarterly Report

PROLOR BIOTECH, INC.

0001144204-12-060438

← back to feed
Filed
Nov 8, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Oct 31, 2012 63.41M sh
Capex Q3 2012 · Sep 30, 2012 $217.03K
Capex Q3 2012 · Sep 30, 2012 $1.56M
Capex Q3 2012 · Sep 30, 2011 $590.76K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$11.35M
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$45.27M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$8.18M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $28.57M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $13.26M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $15.97M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $24.47M
Stockholders Equity Q3 2012 · Sep 30, 2012 $37.58M
Stockholders Equity Q3 2012 · Dec 31, 2011 $12.52M
Current Liabilities Q3 2012 · Sep 30, 2012 $3.05M
Current Liabilities Q3 2012 · Dec 31, 2011 $2.22M
Current Assets Q3 2012 · Sep 30, 2012 $39.73M
Current Assets Q3 2012 · Dec 31, 2011 $13.83M
Total Assets Q3 2012 · Sep 30, 2012 $40.97M
Total Assets Q3 2012 · Dec 31, 2011 $15.02M
Sga Expense Q3 2012 · Sep 30, 2012 −$866.62K
Sga Expense Q3 2012 · Sep 30, 2012 −$2.52M
Sga Expense Q3 2012 · Sep 30, 2012 −$19.62M
Sga Expense restated Q3 2012 · Sep 30, 2011 −$808.27K
Sga Expense restated Q3 2012 · Sep 30, 2011 −$2.4M
Net Income Q3 2012 · Sep 30, 2012 −$5.5M
Net Income Q3 2012 · Sep 30, 2012 −$13.57M
Net Income Q3 2012 · Sep 30, 2012 −$63.22M
Net Income Q3 2012 · Sep 30, 2011 −$3.48M
Net Income Q3 2012 · Sep 30, 2011 −$10.04M
Operating Income Q3 2012 · Sep 30, 2012 −$5.6M
Operating Income Q3 2012 · Sep 30, 2012 −$13.67M
Operating Income Q3 2012 · Sep 30, 2012 −$63.74M
Operating Income Q3 2012 · Sep 30, 2011 −$2.93M
Operating Income Q3 2012 · Sep 30, 2011 −$9.93M